Improved cancer therapy based on tumor associated antigens derived from cyclin D1

• 收藏
• 分享

专利权人:

immatics biotechnologies GmbH

发明人:

Singh, Harpreet,Weinschenk, Toni,Walter, Steffen

申请号：

AU2011260277

公开号：

AU2011260277B2

申请日:

2011.06.01

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

The present invention relates to cyclin D1-derived peptides for use in the improved treatment of cancer in a patient, particularly in the form of a combination therapy using a vaccine. Other aspects relate to the use of the peptides or a combination thereof as a diagnostic tool.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/